佳都科技(600728.SH):新科佳都牽頭中標約12.91億元成都軌道交通相關項目
格隆匯4月6日丨佳都科技(600728.SH)公佈,近日,佳都科技集團股份有限公司全資子公司廣州新科佳都科技有限公司(簡稱“新科佳都”)作為聯合體牽頭人,與中鐵十四局集團電氣化工程有限公司(簡稱“中鐵十四局”)、中鐵二局集團電務工程有限公司(簡稱“中鐵二局”)聯合體,收到成都軌道交通集團有限公司發來的中標通知書(軌道集團中字[2022]028號),確定新科佳都、中鐵十四局、中鐵二局聯合體為成都軌道交通17號線二期、18號線三期、19號線二期工程綜合監控(含通信)系統集成及安裝項目的中標單位。中標總金額為約12.91億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.